These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland. Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629 [TBL] [Abstract][Full Text] [Related]
7. A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects. Summers MA; O'Dorisio MS; Cox MO; Lara-Marquez M; Goetzl EJ J Pharmacol Exp Ther; 2003 Aug; 306(2):638-45. PubMed ID: 12750439 [TBL] [Abstract][Full Text] [Related]
8. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes. Akesson L; Ahrén B; Edgren G; Degerman E Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088 [TBL] [Abstract][Full Text] [Related]
9. Alterations in the relative abundance of the vasoactive intestinal peptide receptors (VPAC1 and VPAC2) and functions in uterine contractility during inflammation. Palus K; Całka J; Jana B Anim Reprod Sci; 2021 Feb; 225():106680. PubMed ID: 33388613 [TBL] [Abstract][Full Text] [Related]
10. Location and function of VPAC1, VPAC2 and NPR-C receptors in VIP-induced vasodilation of porcine basilar arteries. Grant S; Lutz EM; McPhaden AR; Wadsworth RM J Cereb Blood Flow Metab; 2006 Jan; 26(1):58-67. PubMed ID: 15959462 [TBL] [Abstract][Full Text] [Related]
11. Cholinergic activation of enteric glia is a physiological mechanism that contributes to the regulation of gastrointestinal motility. Delvalle NM; Fried DE; Rivera-Lopez G; Gaudette L; Gulbransen BD Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G473-G483. PubMed ID: 29927320 [TBL] [Abstract][Full Text] [Related]
12. VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production. Kojima M; Ito T; Oono T; Hisano T; Igarashi H; Arita Y; Kawabe K; Coy DH; Jensen RT; Nawata H Pancreas; 2005 Jan; 30(1):62-70. PubMed ID: 15632701 [TBL] [Abstract][Full Text] [Related]
13. Purinergic neuron-to-glia signaling in the enteric nervous system. Gulbransen BD; Sharkey KA Gastroenterology; 2009 Apr; 136(4):1349-58. PubMed ID: 19250649 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of vasoactive intestinal peptide-elicited coronary vasodilation in the isolated perfused rat heart. Sawmiller DR; Ashtari M; Urueta H; Leschinsky M; Henning RJ Neuropeptides; 2006 Oct; 40(5):349-55. PubMed ID: 17030371 [TBL] [Abstract][Full Text] [Related]
15. Evidence for the involvement of VPAC1 and VPAC2 receptors in pressure-induced vasodilatation in rodents. Fizanne L; Sigaudo-Roussel D; Saumet JL; Fromy B J Physiol; 2004 Jan; 554(Pt 2):519-28. PubMed ID: 14578481 [TBL] [Abstract][Full Text] [Related]
16. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals. Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855 [TBL] [Abstract][Full Text] [Related]
17. Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion. Csati A; Tajti J; Kuris A; Tuka B; Edvinsson L; Warfvinge K Neuroscience; 2012 Jan; 202():158-68. PubMed ID: 22108610 [TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies. Schulz S; Röcken C; Mawrin C; Weise W; Höllt V; Schulz S Clin Cancer Res; 2004 Dec; 10(24):8235-42. PubMed ID: 15623599 [TBL] [Abstract][Full Text] [Related]